HK2 and ovarian cancer: LncRNA-OIP5‐AS1 is an upregulated lncRNA in ovarian cancer; lncRNA-OIP5‐AS1 knockdown downregulates hexokinase-2 protein expression and decreases glycolysis in ovarian cancer (Liu et al., 2021[80]).